Stanford Program to Accelerate Robotic Children's Surgery
The goal of this clinical trial is to provide additional data to confirm safety and performance of the da Vinci Xi Surgical System in a human clinical setting. This pilot study is intended to provide an initial assessment to evaluate the feasibility, safety, and effectiveness for the utilization of the da Vinci Xi on pediatric and adolescent patients. This clinical trial will be conducted under the auspices of Stanford University's IRB approval.
• Subject is between 6 - 21 years of age (weighing at least 15 kilograms)
• Subject clinically diagnosed with a medical condition for which one of the study procedures is appropriate therapy and selected as the treatment of choice by the guardian and surgeon.
• Subject without previous treatment using a robotic surgery device
• Subject or their guardian is willing and able to provide written informed consent
• Subject or their guardian is willing and able to comply with the study protocol requirements